Practical Applications for Single Pill Combinations in the Cardiovascular Continuum

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz, Giuseppe Rosano, Maurizio Volterrani

Research output: Contribution to journalArticlepeer-review


Despite the availability of new drugs and devices, the treatment of cardiovascular disease remains suboptimal. Single-pill combination therapy offers a number of potential advantages. It can combine different classes of drugs to increase efficacy while mitigating the risks of treatment-related adverse events, reduce pill burden, lower medical cost, and improve patient adherence. Furthermore, in hypertension, single pill combinations include standard to lower doses of each drug than would be necessary to achieve goals with monotherapy, which may explain their better tolerability compared with higher dose monotherapy. Combination therapy is now established in the treatment of hypertension. In ischaemic heart disease, the concept of a preventative polypill has been studied, but its benefits have not been established conclusively. However, the combination of ivabradine and beta-blockers has proven efficacy in patients with stable angina pectoris. This combination has also demonstrated benefits in patients with chronic heart failure.

Original languageEnglish
Pages (from-to)40-45
Number of pages6
JournalCardiac Failure Review
Issue number1
Publication statusPublished - Apr 2017


Dive into the research topics of 'Practical Applications for Single Pill Combinations in the Cardiovascular Continuum'. Together they form a unique fingerprint.

Cite this